SlideShare une entreprise Scribd logo
1  sur  14
Télécharger pour lire hors ligne
Community Viral Load Measurement

              Myron S. Cohen
   University of North Carolina at Chapel Hill
ART STOPS HIV Transmission
               NEJM Aug 11, 2011
But … Community Viral Load?
        Wood et al. BMJ, 2008
• Mean “one-time” blood viral load in a cohort
• Has been used to “associate” cohort viral
  load with HIV “incidence”
Community Viral Load: A BAD IDEA
• No denominators (who actually has HIV?)
• No true numerator
  -longitudinal viral load not measured
  - patients “lost to care” disappear
  -spacial geography may not be noted
  -report of a mean confuses evaluation
• Obscures the role of acute infection
Acute HIV-1 Infection
                                                         Window of Opportunity                        Point of No Return
Virus Concentration in Extracellular Fluid




                                             108
                                             107                                  Symptoms
                                             106
                                             105                                                Set Point
          Plasma (Copies/ml)




                                             104
                                             103                               Reservoir
                                             102
                                             101
                   or




                                               0
                                                                        Virus                              Limit of detection of
                                             10-1
                                                                        dissemination                       assay for plasma
                                             10-2       Transit                                                    virus
                                             10-3
                                             10-4
                                             10-5
                                                    0        5    10   15    20   25       30    35   40        45    50    55     60   65   70


                                                                            Time Post Exposure (days)
                                     Transmission
Effect of Acute and Early HIV Infection on Spread
                                                                                             Cohen et al, NEJM, 2011
                                                                          Pinkerton & Abramson 1996**
                                                                                                                  Kretzschmar & Dietz 1998**†




                                            Powers et al 2010

                                Salomon &                                        Jacquez et al 1994
                  Hayes &
                                                                                                            Koopman et al 1997**
                  White         Hogan
                  2006*         2008*
                                                                                                                                            Xiridou et al 2004




                                                                Pinkerton 2007


                                                                        Prabhu et al 2009

                                              Hollingsworth
                 Abu-Raddad
                                              et al 2008
                 & Longini 2008†




* Range of estimates reflects the proportion of all transmissions during an individual’s entire infectious period that occur during EHI. The extent to which this
proportion corresponds with the proportion of all transmissions that occur during EHI at the population level will depend on the epidemic phase and the distribution
of sexual contact patterns in the population.
** Transmission probabilities were drawn from the population category shown, but the reported estimates result from a range of hypothetical sexual behavior
parameters that do not necessarily reflect a specific population.
 † The range of estimates shown was extracted from the endemic-phase portion of graphs showing the proportion of new infections due to EHI over calendar time.
The Real Community Viral Load?
For each new diagnosis 10% AHI missed
 (Patel, Archives Int Med, 2010)
SO…multiply CVL x 10% X 1,000,000 copies/ml
For Example: San Francisco (Das, PLoS, 2010)
  434 “new diagnosis” in 2008
    - Reported community viral load ~15,000?
       But 43,000,000 copies of HIV are missing!
Community viral load obscures critical information
What is the US Community Viral Load?
                                                                        Gardner et al CID, 2011




Figure 2. The spectrum of engagement in HIV care in the United States spanning from HIV acquisition to full engagement
in care, receipt of antiretroviral therapy, and achievement of complete viral suppression. We estimate that only 19% of
HIV-infected individuals in the United States have an undetectable HIV load.
Reporting HIV Incidence:
               A parallel problem
Seroconversion in a cohort: (the gold standard)

• Biological cross-sectional assay of “new” antibodies?
       -BED?
      - avidity
       -new assays (IgG3)
       -algorithms

• New Diagnosis modeled for incidence (Wand, AIDSBehav.2011) ?

      New diagnosis is NOT incidence, and relationship to
       incidence depends on population specific assumptions
       about disease progression
Ecology and ART
• San Francisco
  Das et al. PLoS One, 2010
• British Columbia
  Montaner et al Lancet, 2010

  No Denominator
  No Numerator
  No measurement of actual HIV “incidence”

…and Australia, the Netherlands and the US (Plos
One, August 2011) see NO decrease in HIV incidence in
spite of widespread usage of ART!
British Columbia and ART?
Lancet, Montaner, 2010: “NEW DIAGNOSIS”
IDU , BC and Adherence to ART
           Nolan et al. AIDS Care, 2011
• 267 antiretroviral naïve IDU (1996-2007)
• 51 months of treatment follow-up
• 81 (30.3%) 95% adherent in 1st year of HART
• 187 (70.0%) achieved HIV suppression once
  once over the study
• These subjects are not reliably suppressed!
Measuring HIV Prevention and Effects of ART
• Focus on a REAL denominator
      -undiagnosed HIV in the population
      -lost to follow up
      -acute infection
• Generate a REAL numerator
  -longitudinal viral load(s)
   -more geography
   -treatment resistance and failure

• Acute HIV Infection: Ignorance is NOT bliss
Why is this Important?
• HIV prevention depends on implementation of
  a clear, evidenced based strategy
• ART STOPS heterosexual transmission of HIV!
• Observational ecologic reports may or MAY
  NOT reflect reduced “incidence” of HIV
• We need reliable outcome measurements
  …not “community viral load”

Contenu connexe

Similaire à 3 tue cohen tue cdc cvl august 16 final

Michael Ison USA - Monday 28 - Traceability and Biovigilance
Michael Ison   USA - Monday 28 - Traceability and BiovigilanceMichael Ison   USA - Monday 28 - Traceability and Biovigilance
Michael Ison USA - Monday 28 - Traceability and Biovigilanceincucai_isodp
 
Hiv prophylaxis-following-occupational-exposure-12-04-2012
Hiv prophylaxis-following-occupational-exposure-12-04-2012Hiv prophylaxis-following-occupational-exposure-12-04-2012
Hiv prophylaxis-following-occupational-exposure-12-04-2012Masbelle Opencel
 
A Clinical Trial of CCR5 Inhibition in Treated HIV Infection: Highlighting Mu...
A Clinical Trial of CCR5 Inhibition in Treated HIV Infection: Highlighting Mu...A Clinical Trial of CCR5 Inhibition in Treated HIV Infection: Highlighting Mu...
A Clinical Trial of CCR5 Inhibition in Treated HIV Infection: Highlighting Mu...CTSI at UCSF
 
Neonatal nosocomial infections
Neonatal nosocomial infectionsNeonatal nosocomial infections
Neonatal nosocomial infectionsMCH-org-ua
 
Jacinto Sanchez Ibañez - Spain - Tuesday 29 - Donor Risk
Jacinto Sanchez Ibañez  - Spain - Tuesday 29 -  Donor RiskJacinto Sanchez Ibañez  - Spain - Tuesday 29 -  Donor Risk
Jacinto Sanchez Ibañez - Spain - Tuesday 29 - Donor Riskincucai_isodp
 
Chapter 2.2 screening test
Chapter 2.2 screening testChapter 2.2 screening test
Chapter 2.2 screening testNilesh Kucha
 
4 u1.0-b978-1-4160-4224-2..50019-3..docpdf
4 u1.0-b978-1-4160-4224-2..50019-3..docpdf4 u1.0-b978-1-4160-4224-2..50019-3..docpdf
4 u1.0-b978-1-4160-4224-2..50019-3..docpdfLoveis1able Khumpuangdee
 
Hiv eye update 2013
Hiv eye update 2013Hiv eye update 2013
Hiv eye update 2013etedaldi
 
7.1 risk perception_and_the_stigma_of_hiv_and_aids_why_routine_testing_will_c...
7.1 risk perception_and_the_stigma_of_hiv_and_aids_why_routine_testing_will_c...7.1 risk perception_and_the_stigma_of_hiv_and_aids_why_routine_testing_will_c...
7.1 risk perception_and_the_stigma_of_hiv_and_aids_why_routine_testing_will_c...Programa_BRIC
 
The 18th International AIDS Conference (AIDS 2010)
The 18th International AIDS Conference (AIDS 2010)The 18th International AIDS Conference (AIDS 2010)
The 18th International AIDS Conference (AIDS 2010)Abhishek Shah
 
Impact of hiv naat in texas nine months and counting-myra brinson - texas h...
Impact of hiv naat in texas   nine months and counting-myra brinson - texas h...Impact of hiv naat in texas   nine months and counting-myra brinson - texas h...
Impact of hiv naat in texas nine months and counting-myra brinson - texas h...DSHS
 
2008 Aids Community Support & Art Outcomes S Afr Edwin Wouters
2008 Aids Community Support & Art Outcomes S Afr Edwin Wouters2008 Aids Community Support & Art Outcomes S Afr Edwin Wouters
2008 Aids Community Support & Art Outcomes S Afr Edwin Wouterswvdamme
 

Similaire à 3 tue cohen tue cdc cvl august 16 final (20)

Top Ten HIV Clinical Controversies 2014
Top Ten HIV Clinical Controversies 2014Top Ten HIV Clinical Controversies 2014
Top Ten HIV Clinical Controversies 2014
 
Michael Ison USA - Monday 28 - Traceability and Biovigilance
Michael Ison   USA - Monday 28 - Traceability and BiovigilanceMichael Ison   USA - Monday 28 - Traceability and Biovigilance
Michael Ison USA - Monday 28 - Traceability and Biovigilance
 
Hiv prophylaxis-following-occupational-exposure-12-04-2012
Hiv prophylaxis-following-occupational-exposure-12-04-2012Hiv prophylaxis-following-occupational-exposure-12-04-2012
Hiv prophylaxis-following-occupational-exposure-12-04-2012
 
A Clinical Trial of CCR5 Inhibition in Treated HIV Infection: Highlighting Mu...
A Clinical Trial of CCR5 Inhibition in Treated HIV Infection: Highlighting Mu...A Clinical Trial of CCR5 Inhibition in Treated HIV Infection: Highlighting Mu...
A Clinical Trial of CCR5 Inhibition in Treated HIV Infection: Highlighting Mu...
 
Neonatal nosocomial infections
Neonatal nosocomial infectionsNeonatal nosocomial infections
Neonatal nosocomial infections
 
Update and Guidance on PrEP for Clinicians
Update and Guidance on PrEP for CliniciansUpdate and Guidance on PrEP for Clinicians
Update and Guidance on PrEP for Clinicians
 
Barriers of HIV Prevention through Treatment
Barriers of HIV Prevention through TreatmentBarriers of HIV Prevention through Treatment
Barriers of HIV Prevention through Treatment
 
Jacinto Sanchez Ibañez - Spain - Tuesday 29 - Donor Risk
Jacinto Sanchez Ibañez  - Spain - Tuesday 29 -  Donor RiskJacinto Sanchez Ibañez  - Spain - Tuesday 29 -  Donor Risk
Jacinto Sanchez Ibañez - Spain - Tuesday 29 - Donor Risk
 
Schuez
SchuezSchuez
Schuez
 
Chapter 2.2 screening test
Chapter 2.2 screening testChapter 2.2 screening test
Chapter 2.2 screening test
 
Gene Xpert & Advances
Gene Xpert & AdvancesGene Xpert & Advances
Gene Xpert & Advances
 
4 u1.0-b978-1-4160-4224-2..50019-3..docpdf
4 u1.0-b978-1-4160-4224-2..50019-3..docpdf4 u1.0-b978-1-4160-4224-2..50019-3..docpdf
4 u1.0-b978-1-4160-4224-2..50019-3..docpdf
 
Importance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment earlyImportance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment early
 
Hiv eye update 2013
Hiv eye update 2013Hiv eye update 2013
Hiv eye update 2013
 
7.1 risk perception_and_the_stigma_of_hiv_and_aids_why_routine_testing_will_c...
7.1 risk perception_and_the_stigma_of_hiv_and_aids_why_routine_testing_will_c...7.1 risk perception_and_the_stigma_of_hiv_and_aids_why_routine_testing_will_c...
7.1 risk perception_and_the_stigma_of_hiv_and_aids_why_routine_testing_will_c...
 
2016 Sessions: Approach to STI Management in HIV
2016 Sessions: Approach to STI Management in HIV2016 Sessions: Approach to STI Management in HIV
2016 Sessions: Approach to STI Management in HIV
 
The 18th International AIDS Conference (AIDS 2010)
The 18th International AIDS Conference (AIDS 2010)The 18th International AIDS Conference (AIDS 2010)
The 18th International AIDS Conference (AIDS 2010)
 
Impact of hiv naat in texas nine months and counting-myra brinson - texas h...
Impact of hiv naat in texas   nine months and counting-myra brinson - texas h...Impact of hiv naat in texas   nine months and counting-myra brinson - texas h...
Impact of hiv naat in texas nine months and counting-myra brinson - texas h...
 
journal.pone.0006828.PDF
journal.pone.0006828.PDFjournal.pone.0006828.PDF
journal.pone.0006828.PDF
 
2008 Aids Community Support & Art Outcomes S Afr Edwin Wouters
2008 Aids Community Support & Art Outcomes S Afr Edwin Wouters2008 Aids Community Support & Art Outcomes S Afr Edwin Wouters
2008 Aids Community Support & Art Outcomes S Afr Edwin Wouters
 

Plus de CDC NPIN

NPIN By The Numbers 2014: Twitter
NPIN By The Numbers 2014: TwitterNPIN By The Numbers 2014: Twitter
NPIN By The Numbers 2014: TwitterCDC NPIN
 
NPIN By The Numbers 2014: SlideShare
NPIN By The Numbers 2014: SlideShareNPIN By The Numbers 2014: SlideShare
NPIN By The Numbers 2014: SlideShareCDC NPIN
 
NPIN By The Numbers 2014: LinkedIn
NPIN By The Numbers 2014: LinkedInNPIN By The Numbers 2014: LinkedIn
NPIN By The Numbers 2014: LinkedInCDC NPIN
 
NPIN By The Numbers 2014: Facebook
NPIN By The Numbers 2014: FacebookNPIN By The Numbers 2014: Facebook
NPIN By The Numbers 2014: FacebookCDC NPIN
 
NPIN's New Technologies Coming Soon!
NPIN's New Technologies Coming Soon!NPIN's New Technologies Coming Soon!
NPIN's New Technologies Coming Soon!CDC NPIN
 
NPIN's New Technology Coming Soon:STD Awareness Microsite
NPIN's New Technology Coming Soon:STD Awareness MicrositeNPIN's New Technology Coming Soon:STD Awareness Microsite
NPIN's New Technology Coming Soon:STD Awareness MicrositeCDC NPIN
 
NPIN's New Technology Coming Soon: CDCNPIN.org goes Social
NPIN's New Technology Coming Soon: CDCNPIN.org goes SocialNPIN's New Technology Coming Soon: CDCNPIN.org goes Social
NPIN's New Technology Coming Soon: CDCNPIN.org goes SocialCDC NPIN
 
NPIN's New Technology Coming Soon: New Testing and Treatment Widget
NPIN's New Technology Coming Soon: New Testing and Treatment WidgetNPIN's New Technology Coming Soon: New Testing and Treatment Widget
NPIN's New Technology Coming Soon: New Testing and Treatment WidgetCDC NPIN
 
NPIN's New Technology Coming Soon: Gettested.cdc.gov
NPIN's New Technology Coming Soon: Gettested.cdc.gov NPIN's New Technology Coming Soon: Gettested.cdc.gov
NPIN's New Technology Coming Soon: Gettested.cdc.gov CDC NPIN
 
In the Know II: What's New In Image & Video Sharing?
In the Know II:  What's New In Image & Video Sharing?In the Know II:  What's New In Image & Video Sharing?
In the Know II: What's New In Image & Video Sharing?CDC NPIN
 
In the Know 2: Whats New in Social Media?
In the Know 2: Whats New in Social Media? In the Know 2: Whats New in Social Media?
In the Know 2: Whats New in Social Media? CDC NPIN
 
Using What You Know about Social Media: How to Conduct a Twitter Chat
Using What You Know about Social Media: How to Conduct a Twitter ChatUsing What You Know about Social Media: How to Conduct a Twitter Chat
Using What You Know about Social Media: How to Conduct a Twitter ChatCDC NPIN
 
In the Know II: Creating Your Social Media Plan
In the Know II: Creating Your Social Media PlanIn the Know II: Creating Your Social Media Plan
In the Know II: Creating Your Social Media PlanCDC NPIN
 
AIDS Memorial Quilts
AIDS Memorial QuiltsAIDS Memorial Quilts
AIDS Memorial QuiltsCDC NPIN
 
NPIN by the Numbers 2011 2012
NPIN by the Numbers 2011 2012NPIN by the Numbers 2011 2012
NPIN by the Numbers 2011 2012CDC NPIN
 
NPIN's In the Know: Social Media for Public Health Webcast Series Poster
NPIN's In the Know: Social Media for Public Health Webcast Series PosterNPIN's In the Know: Social Media for Public Health Webcast Series Poster
NPIN's In the Know: Social Media for Public Health Webcast Series PosterCDC NPIN
 
CDC NPIN In the Know: Social Media Measurement and Evaluation for Public Heal...
CDC NPIN In the Know: Social Media Measurement and Evaluation for Public Heal...CDC NPIN In the Know: Social Media Measurement and Evaluation for Public Heal...
CDC NPIN In the Know: Social Media Measurement and Evaluation for Public Heal...CDC NPIN
 
CDC NPIN In the Know: Google Plus & YouTube for Public Health
CDC NPIN In the Know: Google Plus & YouTube for Public HealthCDC NPIN In the Know: Google Plus & YouTube for Public Health
CDC NPIN In the Know: Google Plus & YouTube for Public HealthCDC NPIN
 
CDC NPIN In the Know: Facebook & Visual Social Media for Public Health
CDC NPIN In the Know: Facebook & Visual Social Media for Public HealthCDC NPIN In the Know: Facebook & Visual Social Media for Public Health
CDC NPIN In the Know: Facebook & Visual Social Media for Public HealthCDC NPIN
 
CDC NPIN In the Know: Gaming & Mobile for Public Health Webcast Presentation
CDC NPIN In the Know: Gaming & Mobile for Public Health Webcast PresentationCDC NPIN In the Know: Gaming & Mobile for Public Health Webcast Presentation
CDC NPIN In the Know: Gaming & Mobile for Public Health Webcast PresentationCDC NPIN
 

Plus de CDC NPIN (20)

NPIN By The Numbers 2014: Twitter
NPIN By The Numbers 2014: TwitterNPIN By The Numbers 2014: Twitter
NPIN By The Numbers 2014: Twitter
 
NPIN By The Numbers 2014: SlideShare
NPIN By The Numbers 2014: SlideShareNPIN By The Numbers 2014: SlideShare
NPIN By The Numbers 2014: SlideShare
 
NPIN By The Numbers 2014: LinkedIn
NPIN By The Numbers 2014: LinkedInNPIN By The Numbers 2014: LinkedIn
NPIN By The Numbers 2014: LinkedIn
 
NPIN By The Numbers 2014: Facebook
NPIN By The Numbers 2014: FacebookNPIN By The Numbers 2014: Facebook
NPIN By The Numbers 2014: Facebook
 
NPIN's New Technologies Coming Soon!
NPIN's New Technologies Coming Soon!NPIN's New Technologies Coming Soon!
NPIN's New Technologies Coming Soon!
 
NPIN's New Technology Coming Soon:STD Awareness Microsite
NPIN's New Technology Coming Soon:STD Awareness MicrositeNPIN's New Technology Coming Soon:STD Awareness Microsite
NPIN's New Technology Coming Soon:STD Awareness Microsite
 
NPIN's New Technology Coming Soon: CDCNPIN.org goes Social
NPIN's New Technology Coming Soon: CDCNPIN.org goes SocialNPIN's New Technology Coming Soon: CDCNPIN.org goes Social
NPIN's New Technology Coming Soon: CDCNPIN.org goes Social
 
NPIN's New Technology Coming Soon: New Testing and Treatment Widget
NPIN's New Technology Coming Soon: New Testing and Treatment WidgetNPIN's New Technology Coming Soon: New Testing and Treatment Widget
NPIN's New Technology Coming Soon: New Testing and Treatment Widget
 
NPIN's New Technology Coming Soon: Gettested.cdc.gov
NPIN's New Technology Coming Soon: Gettested.cdc.gov NPIN's New Technology Coming Soon: Gettested.cdc.gov
NPIN's New Technology Coming Soon: Gettested.cdc.gov
 
In the Know II: What's New In Image & Video Sharing?
In the Know II:  What's New In Image & Video Sharing?In the Know II:  What's New In Image & Video Sharing?
In the Know II: What's New In Image & Video Sharing?
 
In the Know 2: Whats New in Social Media?
In the Know 2: Whats New in Social Media? In the Know 2: Whats New in Social Media?
In the Know 2: Whats New in Social Media?
 
Using What You Know about Social Media: How to Conduct a Twitter Chat
Using What You Know about Social Media: How to Conduct a Twitter ChatUsing What You Know about Social Media: How to Conduct a Twitter Chat
Using What You Know about Social Media: How to Conduct a Twitter Chat
 
In the Know II: Creating Your Social Media Plan
In the Know II: Creating Your Social Media PlanIn the Know II: Creating Your Social Media Plan
In the Know II: Creating Your Social Media Plan
 
AIDS Memorial Quilts
AIDS Memorial QuiltsAIDS Memorial Quilts
AIDS Memorial Quilts
 
NPIN by the Numbers 2011 2012
NPIN by the Numbers 2011 2012NPIN by the Numbers 2011 2012
NPIN by the Numbers 2011 2012
 
NPIN's In the Know: Social Media for Public Health Webcast Series Poster
NPIN's In the Know: Social Media for Public Health Webcast Series PosterNPIN's In the Know: Social Media for Public Health Webcast Series Poster
NPIN's In the Know: Social Media for Public Health Webcast Series Poster
 
CDC NPIN In the Know: Social Media Measurement and Evaluation for Public Heal...
CDC NPIN In the Know: Social Media Measurement and Evaluation for Public Heal...CDC NPIN In the Know: Social Media Measurement and Evaluation for Public Heal...
CDC NPIN In the Know: Social Media Measurement and Evaluation for Public Heal...
 
CDC NPIN In the Know: Google Plus & YouTube for Public Health
CDC NPIN In the Know: Google Plus & YouTube for Public HealthCDC NPIN In the Know: Google Plus & YouTube for Public Health
CDC NPIN In the Know: Google Plus & YouTube for Public Health
 
CDC NPIN In the Know: Facebook & Visual Social Media for Public Health
CDC NPIN In the Know: Facebook & Visual Social Media for Public HealthCDC NPIN In the Know: Facebook & Visual Social Media for Public Health
CDC NPIN In the Know: Facebook & Visual Social Media for Public Health
 
CDC NPIN In the Know: Gaming & Mobile for Public Health Webcast Presentation
CDC NPIN In the Know: Gaming & Mobile for Public Health Webcast PresentationCDC NPIN In the Know: Gaming & Mobile for Public Health Webcast Presentation
CDC NPIN In the Know: Gaming & Mobile for Public Health Webcast Presentation
 

Dernier

The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 

Dernier (20)

The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 

3 tue cohen tue cdc cvl august 16 final

  • 1. Community Viral Load Measurement Myron S. Cohen University of North Carolina at Chapel Hill
  • 2. ART STOPS HIV Transmission NEJM Aug 11, 2011
  • 3. But … Community Viral Load? Wood et al. BMJ, 2008 • Mean “one-time” blood viral load in a cohort • Has been used to “associate” cohort viral load with HIV “incidence”
  • 4. Community Viral Load: A BAD IDEA • No denominators (who actually has HIV?) • No true numerator -longitudinal viral load not measured - patients “lost to care” disappear -spacial geography may not be noted -report of a mean confuses evaluation • Obscures the role of acute infection
  • 5. Acute HIV-1 Infection Window of Opportunity Point of No Return Virus Concentration in Extracellular Fluid 108 107 Symptoms 106 105 Set Point Plasma (Copies/ml) 104 103 Reservoir 102 101 or 0 Virus Limit of detection of 10-1 dissemination assay for plasma 10-2 Transit virus 10-3 10-4 10-5 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 Time Post Exposure (days) Transmission
  • 6. Effect of Acute and Early HIV Infection on Spread Cohen et al, NEJM, 2011 Pinkerton & Abramson 1996** Kretzschmar & Dietz 1998**† Powers et al 2010 Salomon & Jacquez et al 1994 Hayes & Koopman et al 1997** White Hogan 2006* 2008* Xiridou et al 2004 Pinkerton 2007 Prabhu et al 2009 Hollingsworth Abu-Raddad et al 2008 & Longini 2008† * Range of estimates reflects the proportion of all transmissions during an individual’s entire infectious period that occur during EHI. The extent to which this proportion corresponds with the proportion of all transmissions that occur during EHI at the population level will depend on the epidemic phase and the distribution of sexual contact patterns in the population. ** Transmission probabilities were drawn from the population category shown, but the reported estimates result from a range of hypothetical sexual behavior parameters that do not necessarily reflect a specific population. † The range of estimates shown was extracted from the endemic-phase portion of graphs showing the proportion of new infections due to EHI over calendar time.
  • 7. The Real Community Viral Load? For each new diagnosis 10% AHI missed (Patel, Archives Int Med, 2010) SO…multiply CVL x 10% X 1,000,000 copies/ml For Example: San Francisco (Das, PLoS, 2010) 434 “new diagnosis” in 2008 - Reported community viral load ~15,000? But 43,000,000 copies of HIV are missing! Community viral load obscures critical information
  • 8. What is the US Community Viral Load? Gardner et al CID, 2011 Figure 2. The spectrum of engagement in HIV care in the United States spanning from HIV acquisition to full engagement in care, receipt of antiretroviral therapy, and achievement of complete viral suppression. We estimate that only 19% of HIV-infected individuals in the United States have an undetectable HIV load.
  • 9. Reporting HIV Incidence: A parallel problem Seroconversion in a cohort: (the gold standard) • Biological cross-sectional assay of “new” antibodies? -BED? - avidity -new assays (IgG3) -algorithms • New Diagnosis modeled for incidence (Wand, AIDSBehav.2011) ? New diagnosis is NOT incidence, and relationship to incidence depends on population specific assumptions about disease progression
  • 10. Ecology and ART • San Francisco Das et al. PLoS One, 2010 • British Columbia Montaner et al Lancet, 2010 No Denominator No Numerator No measurement of actual HIV “incidence” …and Australia, the Netherlands and the US (Plos One, August 2011) see NO decrease in HIV incidence in spite of widespread usage of ART!
  • 11. British Columbia and ART? Lancet, Montaner, 2010: “NEW DIAGNOSIS”
  • 12. IDU , BC and Adherence to ART Nolan et al. AIDS Care, 2011 • 267 antiretroviral naïve IDU (1996-2007) • 51 months of treatment follow-up • 81 (30.3%) 95% adherent in 1st year of HART • 187 (70.0%) achieved HIV suppression once once over the study • These subjects are not reliably suppressed!
  • 13. Measuring HIV Prevention and Effects of ART • Focus on a REAL denominator -undiagnosed HIV in the population -lost to follow up -acute infection • Generate a REAL numerator -longitudinal viral load(s) -more geography -treatment resistance and failure • Acute HIV Infection: Ignorance is NOT bliss
  • 14. Why is this Important? • HIV prevention depends on implementation of a clear, evidenced based strategy • ART STOPS heterosexual transmission of HIV! • Observational ecologic reports may or MAY NOT reflect reduced “incidence” of HIV • We need reliable outcome measurements …not “community viral load”